Therapeutic Goods Act 1989
I, Cheryl McRae, Assistant Secretary, Complementary and Over the Counter Medicines Branch, Therapeutic Goods Administration and delegate of the Secretary to the Department of Health for the purposes of section 42 DK (1) of the Therapeutic Goods Act, give notice that the restricted representations described in paragraph (a) below, being representations that are necessary for the appropriate use of the therapeutic goods described in paragraph (b) below, may be included either on the label of the package of the goods or in information included in the package in which those goods are contained:
- Representations to the effect that the goods described in paragraph (b) below may be used to "Reduces the risk of heart attack and stroke in patients with known cardiovascular or cerebrovascular disease, by helping to prevent blood clotting."
- PRICELINE PHARMACY ASPIRIN LOW DOSE aspirin 100mg enteric coated tablet blister pack (AUST R 296677)
supplied as an over-the-counter medicine by the sponsor Soul Pattinson Manufacturing Pty Ltd.
Dated this 18th day of January 2018
Dr Cheryl McRae
Delegate of the Secretary to the Department of Health; and
Assistant Secretary, Complementary and Over the Counter Medicines Branch